DE69330566D1 - Steigerung der transplantattoleranz durch schwein cytokine - Google Patents
Steigerung der transplantattoleranz durch schwein cytokineInfo
- Publication number
- DE69330566D1 DE69330566D1 DE69330566T DE69330566T DE69330566D1 DE 69330566 D1 DE69330566 D1 DE 69330566D1 DE 69330566 T DE69330566 T DE 69330566T DE 69330566 T DE69330566 T DE 69330566T DE 69330566 D1 DE69330566 D1 DE 69330566D1
- Authority
- DE
- Germany
- Prior art keywords
- porcine
- bone marrow
- transplant
- marrow cells
- atolerance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004127 Cytokines Human genes 0.000 title abstract 4
- 108090000695 Cytokines Proteins 0.000 title abstract 4
- 210000002798 bone marrow cell Anatomy 0.000 abstract 4
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96718892A | 1992-10-27 | 1992-10-27 | |
US08/133,979 US5589582A (en) | 1992-10-27 | 1993-10-08 | Polynucleotides en coding porcine cytokines |
PCT/US1993/010295 WO1994009803A1 (en) | 1992-10-27 | 1993-10-26 | Enhancement of xenograft tolerance and porcine cytokines therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69330566D1 true DE69330566D1 (de) | 2001-09-13 |
DE69330566T2 DE69330566T2 (de) | 2002-06-27 |
Family
ID=26831859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69330566T Expired - Fee Related DE69330566T2 (de) | 1992-10-27 | 1993-10-26 | Steigerung der transplantattoleranz durch schwein cytokine |
Country Status (8)
Country | Link |
---|---|
US (3) | US5589582A (de) |
EP (1) | EP0669829B1 (de) |
JP (1) | JP3784063B2 (de) |
AT (1) | ATE204019T1 (de) |
AU (2) | AU5452194A (de) |
CA (1) | CA2147989C (de) |
DE (1) | DE69330566T2 (de) |
WO (1) | WO1994009803A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
GB9515839D0 (en) * | 1995-08-02 | 1995-10-04 | Q One Biotech Ltd | Feline stem cell factor |
US6011197A (en) | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
US6447767B1 (en) | 1997-05-23 | 2002-09-10 | Hadasit Medical Research Services And Development Ltd. | Non-myeloablative tolerogenic treatment |
US6428782B1 (en) | 1997-05-23 | 2002-08-06 | Hadasit Medical Research Services And Development Ltd. | Non-myeloablative tolerogenic treatment |
WO1999009163A1 (en) * | 1997-08-13 | 1999-02-25 | Biotransplant, Inc. | Porcine stem cell factor varients and recombinant cells expressing such polypeptides |
WO1999009141A1 (en) * | 1997-08-14 | 1999-02-25 | Biotransplant, Inc. | Porcine totipotent cells and method for long-term culture |
US6248587B1 (en) * | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
US6703209B1 (en) * | 1998-08-13 | 2004-03-09 | Biotransplant, Inc. | Porcine totipotent cells and method for long-term culture |
US6258998B1 (en) | 1998-11-24 | 2001-07-10 | Infigen, Inc. | Method of cloning porcine animals |
US6700037B2 (en) | 1998-11-24 | 2004-03-02 | Infigen, Inc. | Method of cloning porcine animals |
AU2001234730A1 (en) | 2000-02-01 | 2001-08-14 | Beth Israel Deaconess Medical Center | Method for inhibiting complement activation |
JP2004521877A (ja) * | 2000-11-22 | 2004-07-22 | ジェロン コーポレイション | 多能性幹細胞の同種移植片の寛容化 |
CA2442819A1 (en) * | 2001-03-28 | 2002-10-24 | Nextran, Inc. | Elimination of endogenous porcine retrovirus |
US20020152490A1 (en) * | 2001-04-12 | 2002-10-17 | Philip Lake | Tolerance-inducing thy-marrow composite tissue construct and organ |
US20030124091A1 (en) * | 2001-10-26 | 2003-07-03 | Large Scale Biology Corporation | Endothelial cell derived hematopoietic growth factor |
CA2899360A1 (en) | 2002-08-21 | 2004-04-08 | Revivicor, Inc. | Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
AU2004290006A1 (en) | 2003-11-05 | 2005-05-26 | University Of Pittsburgh | Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region |
CA2857051A1 (en) | 2004-03-17 | 2005-09-29 | David Ayares | Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
US7489849B2 (en) * | 2004-11-03 | 2009-02-10 | Adc Telecommunications, Inc. | Fiber drop terminal |
ES2709176T3 (es) | 2006-08-11 | 2019-04-15 | Life Sciences Res Partners Vzw | Péptidos inmunogénicos y su uso en trastornos inmunitarios |
ES2650236T3 (es) | 2008-02-14 | 2018-01-17 | Life Sciences Research Partners Vzw | Linfocitos T CD4+ con propiedades citolíticas |
CA2715488C (en) * | 2008-02-14 | 2019-09-24 | Life Sciences Research Partners Vzw | Immunogenic control of tumours and tumour cells |
US20100330088A1 (en) * | 2008-02-14 | 2010-12-30 | Jean-Marie Saint-Remy | Strategies to prevent and/or treat immunie responses to soluble allofactors |
WO2009101208A2 (en) | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Immunotherapy targeting intracellular pathogens |
AU2009214038B2 (en) | 2008-02-14 | 2013-08-22 | Katholieke Universiteit Leuven | Elimination of immune responses to viral vectors |
ES2626115T3 (es) * | 2008-02-14 | 2017-07-24 | Life Sciences Research Partners Vzw | Péptidos inmunogénicos y su uso en trasplante |
US9420770B2 (en) | 2009-12-01 | 2016-08-23 | Indiana University Research & Technology Corporation | Methods of modulating thrombocytopenia and modified transgenic pigs |
RU2615460C2 (ru) | 2010-11-25 | 2017-04-04 | Имнейт Сарл | Иммуногенные пептиды для применения в профилактике и/или лечении инфекционных заболеваний, аутоиммунных заболеваний, иммунных ответов на аллогенные факторы, аллергических заболеваний, опухолей, отторжения трансплантата и иммунных ответов против вирусных векторов. используемых для генной терапии или генной вакцинации |
CN103547288B (zh) * | 2011-01-10 | 2016-03-16 | 密执安大学评议会 | 干细胞因子抑制剂 |
GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
JP7090335B2 (ja) | 2015-09-25 | 2022-06-24 | イムサイス エスエー | 治療剤に対する免疫応答を除去するための改善された方法及び化合物 |
SG11201808710UA (en) | 2016-04-19 | 2018-11-29 | Imcyse Sa | Novel immunogenic cd1d binding peptides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5106733A (en) * | 1987-06-25 | 1992-04-21 | Immunex Corporation | Bovine granulocyte-macrophage colony stimulating factor |
WO1990008188A1 (en) * | 1989-01-10 | 1990-07-26 | Amrad Corporation Limited | Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
JP3378962B2 (ja) * | 1991-08-07 | 2003-02-17 | アンダースン,ダブリュー.,フレンチ | 内部リボソームエントリー部位を含むレトロウイルスベクター |
-
1993
- 1993-10-08 US US08/133,979 patent/US5589582A/en not_active Expired - Lifetime
- 1993-10-26 EP EP93925071A patent/EP0669829B1/de not_active Expired - Lifetime
- 1993-10-26 WO PCT/US1993/010295 patent/WO1994009803A1/en active IP Right Grant
- 1993-10-26 AU AU54521/94A patent/AU5452194A/en not_active Abandoned
- 1993-10-26 AT AT93925071T patent/ATE204019T1/de not_active IP Right Cessation
- 1993-10-26 DE DE69330566T patent/DE69330566T2/de not_active Expired - Fee Related
- 1993-10-26 CA CA002147989A patent/CA2147989C/en not_active Expired - Fee Related
- 1993-10-26 JP JP51043494A patent/JP3784063B2/ja not_active Expired - Fee Related
-
1995
- 1995-05-08 US US08/436,890 patent/US5858963A/en not_active Expired - Lifetime
- 1995-05-26 US US08/451,213 patent/US5863528A/en not_active Expired - Lifetime
-
1998
- 1998-01-02 AU AU50359/98A patent/AU703371B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US5858963A (en) | 1999-01-12 |
AU5035998A (en) | 1998-03-19 |
EP0669829B1 (de) | 2001-08-08 |
AU5452194A (en) | 1994-05-24 |
CA2147989C (en) | 2002-10-22 |
AU703371B2 (en) | 1999-03-25 |
JP3784063B2 (ja) | 2006-06-07 |
WO1994009803A1 (en) | 1994-05-11 |
US5863528A (en) | 1999-01-26 |
CA2147989A1 (en) | 1994-05-11 |
JPH08502650A (ja) | 1996-03-26 |
ATE204019T1 (de) | 2001-08-15 |
DE69330566T2 (de) | 2002-06-27 |
EP0669829A1 (de) | 1995-09-06 |
EP0669829A4 (de) | 1997-05-07 |
US5589582A (en) | 1996-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69330566T2 (de) | Steigerung der transplantattoleranz durch schwein cytokine | |
ATE452190T1 (de) | Verfahren zur isolierung und reinigung von g-csf | |
ATE81779T1 (de) | Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren. | |
ATE297980T1 (de) | Verfahren zur klonierung von schweinen | |
DE69033700D1 (de) | Il-11 aus säugetier | |
MX9305729A (es) | Formulas de proteinas de liberacion sostenida. | |
DE3485759D1 (de) | Reinigung von rekombinanten interleukin-2. | |
DK12990D0 (da) | Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf | |
DE3585084D1 (de) | Verfahren zur reinigung eines proteins. | |
MX9304209A (es) | Composicion y metodo de tratamiento de hepatitis b. | |
ATE226087T1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
DE69535263D1 (de) | Angiotensin ii zur verbesserung der befruchtung | |
DK0687300T3 (da) | LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation | |
DE69527640D1 (de) | Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten | |
ES2142840T3 (es) | Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen. | |
Hawley et al. | Porcine cytokines | |
ATE320266T1 (de) | Induktion von antigen-spezifischen t-zellen durch interferon | |
ATE33842T1 (de) | Immuninterferon und verfahren zu seiner reinigung. | |
DE69122612D1 (de) | Interleukin-4-bindeprotein-gamma | |
FI951325A (fi) | Proteiinien kuljetus membraanien välisellä siirrolla ksenogeenisten elinsiirrännäisten esisovittamista varten ja muihin tarkoituksiin | |
Hawley et al. | Polynucleotides en coding porcine cytokines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |